|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 373 SEK | +4.63% |
|
+17.85% | +13.20% |
| Apr. 24 | Nordic Shares Declined Wednesday; Svenska Handelsbnkn Ser A Fell Furthest | DJ |
| Apr. 24 | Transcript : Xvivo Perfusion AB, Q1 2024 Earnings Call, Apr 24, 2024 |
Xvivo Perfusion AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 597.54 million compared to SEK 415.29 million a year ago. Net income was SEK 91.82 million compared to SEK 18.43 million a year ago.
Basic earnings per share from continuing operations was SEK 3.07 compared to SEK 0.62 a year ago. Diluted earnings per share from continuing operations was SEK 3.07 compared to SEK 0.62 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.20% | 1.07B | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
XVIVO PERFUSION AB 
